['malignant neoplasm', 'solid tumors']
['chloroquine', 'carboplatin', 'gemcitabine']

        Inclusion Criteria:

          -  Histologically confirmed diagnosis of a malignancy that is metastatic or unresectable
             and for which either standard curative measures do not exist or are no longer
             effective and carboplatin/gemcitabine is considered a reasonable treatment option
             whether first line or acceptable and approved combination therapy.

          -  Age >18 years of age.

          -  Performance status less than or equal 2 (Karnofsky >60%)

          -  Life expectancy of greater than 3 months.

          -  Adequate labs

          -  Measurable disease

        Exclusion Criteria:

          -  Current treatment with any other investigational agents.

          -  Patients with untreated brain metastases

          -  History of allergic reaction attributed to compounds of similar chemical or biologic
             composition to chloroquine or other agents used in study.
      